Method For Preparing Solid Formulation Including Sphingosine 1 Phosphate Receptor Agonist

Abstract: The present invention relates to a method for preparing a solid formulation including a sphingosine-1-phosphate receptor agonist and, more specifically, to a method for preparing a solid formulation, in which 1-[1-chloro-6-(3-chloro-1-isopropyl-1H-indazol-5-ylmethoxy)-3,4-dihydro-naphthalene-2-ylmethyl]-piperidine-4-carboxylic acid of chemical formula 1 or a pharmaceutically acceptable salt thereof is blended as an active ingredient with a diluent, a binder, and a disintegrant and the blend is sieved and then mixed to afford a homogenous mixture.

Patent Information

Applicants

Inventors

Specification

Documents

Application Documents